Postmarketing safety profile of brexanolone: many safety signals

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2023年 / 1980卷 / 1期
关键词：
D O I：
10.1007/s40278-023-48203-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [31] Nimotuzumab Cuban Safety Postmarketing Surveillance
    Sierra P., Piedra
    Martinez G, Saurez
    Yanez A, Bencomo
    Iturralde Y, Pomares
    Alvarez M d C, Barroso
    Escobar N, Iznaga
    DRUG SAFETY, 2008, 31 (10) : 892 - 892
  • [32] SAFETY PROFILE OF OCRIPLASMIN FOR SYMPTOMATIC VITREOMACULAR ADHESION A Comprehensive Analysis of Premarketing and Postmarketing Experiences
    Hahn, Paul
    Chung, Mina M.
    Flynn, Harry W., Jr.
    Huang, Suber S.
    Kim, Judy E.
    Mahmoud, Tamer H.
    Sadda, Srinivas R.
    Dugel, Pravin U.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (06): : 1128 - 1134
  • [33] Brexanolone Injection: Efficacy and Safety Data of Patients with postpartum Depression
    Park, S-M
    Meltzer-Brody, S.
    Kanes, S.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2019, 79 (02) : 206 - 206
  • [34] An underrecognized challenge in evaluating postmarketing drug safety
    Roden, DM
    CIRCULATION, 2005, 111 (03) : 246 - 248
  • [35] Postmarketing modifications in the safety labeling of the new antiepileptics
    Buck, Marcia L.
    Gurka, Matthew J.
    Goodkin, Howard P.
    NEUROLOGY, 2007, 68 (18) : 1536 - 1537
  • [36] Postmarketing safety evaluation of belimumab: a pharmacovigilance analysis
    Li, Huqun
    Xie, Wenlong
    Wang, Chongshu
    Guo, Cuilian
    LUPUS SCIENCE & MEDICINE, 2025, 12 (01):
  • [37] Postmarketing evaluation of the safety and effectiveness of varicella vaccine
    Black, S
    Shinefield, H
    Ray, P
    Lewis, E
    Hansen, J
    Schwalbe, J
    Coplan, P
    Sharrar, R
    Guess, H
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (12) : 1041 - 1046
  • [38] Postmarketing modifications in the safety labeling of the new antiepileptics
    Buck, Marcia L.
    Gurka, Matthew J.
    Goodkin, Howard P.
    EPILEPSIA, 2006, 47 : 192 - 192
  • [39] Postmarketing studies on safety of Dengfeng~ shenmai injection
    Lianxin Wang
    Wen Zhang
    Yanming Xie
    Yang Bai
    Mulan Wang
    Qinghua Ai
    JournalofTraditionalChineseMedicine, 2013, 33 (06) : 827 - 831
  • [40] Cardiac safety of diabetes therapies and postmarketing requirements
    Faich, Gerald A.
    Stemhagen, Annette
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 (08) : 787 - 789
12345